Global Health Technologies Coalition member calls for stronger regulatory pathways to expand new products to developing countries

Elias tells graduates decades ahead are full of increased hope–and complexity

Prequalification clears the way for phased introduction of MenAfriVacâ„¢

Respected nonprofit evaluator gives PATH four stars for financial management

PATH brings expertise in HIV/AIDS prevention and survival to 2010 International AIDS Conference

The Pacific Health Summit gathers leaders from varied fields to improve health for mothers and babies

PATH and partners focus on health systems strengthening in inaugural discussion

PATH staff will present on diverse topics at the annual Global Health Council conference, including how to use US investments

Marking the pill’s golden anniversary

Scott Jackson delivers commencement speech at his alma mater

PATH’s president co-chairs InterAction Forum 2010, moderates workshop on integrating health into development programs

At conference, the Global Campaign for Microbicides and partners will help researchers learn how to talk about their work

Global Health Technologies Coalition Congressional briefing highlights US role in research and development

Experts discuss challenges, lessons learned in PATH’s Conversations in Global Health series

PATH joins Mother’s Day initiative to honor mothers around the world

The coalition’s first annual policy report calls for US leadership in global health research and development

PATH global program leader John Wecker, PhD, describes his response to a pledge by the Bill & Melinda Gates Foundation to make this the "decade of vaccines"

An open letter for World Water Day 2010 by Ayo Ajayi, PATH’s vice president of Field Programs

PATH’s president and CEO, Dr. Christopher Elias, serves as commissioner with other global health policy leaders

PATH panelist emphasizes need for low-cost solutions in the field

The first report in the series, co-authored by MACEPA at PATH, addresses malaria control funding in sub-Saharan Africa

PATH participation will help bring efforts to develop new pneumococcal vaccines for low-resource countries into focus

An editorial published this month in Human Vaccines describes our progress, achievements, and major lessons learned